| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.052 | 0.2 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.046 | 0.2 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.067 | 0.2 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | VAF-347 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |